Stock Price Quote

MEDPLUS HEALTH SERVICES LTD.

NSE : MEDPLUSBSE : 543427ISIN CODE : INE804L01022Industry : Pharmaceuticals & DrugsHouse : Private
BSE865.65-7.65 (-0.88 %)
PREV CLOSE ( ) 873.30
OPEN PRICE ( ) 888.90
BID PRICE (QTY) 0.00 (0)
OFFER PRICE (QTY) 0.00 (0)
VOLUME 1709
TODAY'S LOW / HIGH ( )863.95 888.90
52 WK LOW / HIGH ( )603 1052.05
NSE865.80-7.85 (-0.9 %)
PREV CLOSE( ) 873.65
OPEN PRICE ( ) 873.25
BID PRICE (QTY) 0.00 (0)
OFFER PRICE (QTY) 0.00 (0)
VOLUME 69450
TODAY'S LOW / HIGH( ) 864.90 882.40
52 WK LOW / HIGH ( )616 1045.3
1D 1M 3M 1Y 3Y 5Y

STOCK SUMMARY

Incorporation Year : 30-11 2006
Management Info
Gangadi Madhukar Reddy - Chairman Gangadi Madhukar Reddy - Managing Director
Registered Office

Address H. No: 11-6-56, Survey No: 257 & 258/1,Opp: I D P L Railway Siding Road,Moosapet, Kukatpally,
Hyderabad,
Telangana-500037

Phone 040-67246724

Email medplus@medplusindia.com

Website www.medplusindia.com

Registrars Details
K FIN Technologies Ltd.-(Karvy Fintech Pvt Ltd.)
Karvy Selenium Tower B, Plot 31-32,Gachibowli,Financial District,Nanakramguda,Hyderabad
Listing : BSE, NSE

NEWS

04Apr Medplus Health Services informs about
Medplus Health Services has informed that it enclosed revised Disclosure..
25Mar Medplus Health Services submits analys
Pursuant to Regulation 30 read with Schedule III of the SEBI (Listing Ob..
22Feb Medplus Health Services informs about
Medplus Health Services has informed that Optival Health Solutions, a su..
05Feb Medplus Health Services informs about
Medplus Health Services has informed that Monitoring Agency Report dated..
01Feb Medplus Health Services reports over 3
Medplus Health Services has reported results for third quarter ended Dec..

Financials

in Millions
QTR Mar 25 ANNUAL 25
Net Profit139.82403.35
Gross Profit 179.12 511.72
Operating Profit 265.01867.34
Net Sales 2017.517130.97

ROLLING FORWARD P/E (EOD)

EVENT CALENDAR

peer group

RPG Life Sciences (BSE)
peergroup  2417.50 (6.95%)
M.Cap ( in Cr)3998.31
TTK Healthcare (BSE)
peergroup  1287.50 (3.06%)
M.Cap ( in Cr)1819.28
Dr. Reddy's Lab (BSE)
peergroup  1326.40 (1.04%)
M.Cap ( in Cr)110697.51
Biocon (BSE)
peergroup  348.60 (1.89%)
M.Cap ( in Cr)41852.92
Brooks Laboratories (BSE)
peergroup  133.00 (4.72%)
M.Cap ( in Cr)391.78

Shareholding Pattern

PROMOTERS 40.34%
MUTUAL FUNDS/UTI 21.59%
FI/BANKS/INSURANCE 2.26%
NON-INSTITUTION 17.86%
GOVERNMENT 0%
FII 0%

About Medplus Health Services Ltd.

Medplus Health Services Ltd. was incorporated in the year 2006. Its today's share price is 865.65. Its current market capitalisation stands at Rs 10365.59 Cr. In the latest quarter, company has reported Gross Sales of Rs. 5051.58 Cr and Total Income of Rs.4743.23 Cr. The company's management includes Thyagarajan Muralidharan, Aparna Surabhi, Madhavan Ganesan, Murali Sivaraman, Cherukupalli Bhaskar Reddy, Gangadi Madhukar Reddy, Gangadi Madhukar Reddy, Manoj Kumar Srivastava.

It is listed on the BSE with a BSE Code of 543427 , NSE with an NSE Symbol of MEDPLUS and ISIN of INE804L01022. It's Registered office is at H. No: 11-6-56, Survey No: 257 & 258/1,Opp: I D P L Railway Siding Road,Moosapet, KukatpallyHyderabad-500037, Telangana. Their Registrars are K FIN Technologies Ltd.-(Karvy Fintech Pvt Ltd.) It's auditors are BSR & Associates, BSR & Associates LLP, BSR & Co, SR Batliboi & Associates, SR Batliboi & Associates LLP, SR Batliboi & Co LLP

© NIRMAL BANG. All rights reserved

Designed , Developed & Content Powered by Accord Fintech Pvt. Ltd.

Open an Account
FOR AFREE *DEMAT & BROKING ACCOUNT

Please fill in the details below

Close X

(Note - You will receive a call from our sales executive)

CLOSE X

RISK DISCLOSURES ON DERIVATIVES

  • 9 out of 10 individual traders in equity Futures and Options Segment, incurred net losses.
  • On an average, loss makers registered net trading loss close to ₹ 50,000.
  • Over and above the net trading losses incurred, loss makers expended an additional 28% of net trading losses as transaction costs.
  • Those making net trading profits, incurred between 15% to 50% of such profits as transaction cost.

Source:

1. SEBI study dated January 25, 2023 on “Analysis of Profit and Loss of Individual Traders dealing in equity Futures and Options (F&O) Segment”, wherein Aggregate Level findings are based on annual Profit/Loss incurred by individual traders in equity F&O during FY 2021-22.